JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

Search

NeoGenomics Inc

Closed

5.61 -1.06

Overview

Share price change

24h

Current

Min

5.54

Max

5.86

Key metrics

By Trading Economics

Income

-19M

-45M

Sales

13M

181M

Profit margin

-24.867

Employees

2,200

EBITDA

-41M

-48M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+63.84% upside

Dividends

By Dow Jones

Next Earnings

4 lis 2025

Market Stats

By TradingEconomics

Market Cap

-99M

732M

Previous open

6.67

Previous close

5.61

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 sie 2025, 16:50 UTC

Major Market Movers

Verb Technology Shares Double After Private Placement, Intent to Buy Cryptocurrency

31 lip 2025, 20:58 UTC

Earnings

Coinbase Global Misses on 2Q Revenue, Outlook

31 lip 2025, 20:37 UTC

Earnings

MicroStrategy Swings to 2Q Profit on Bitcoin Gains

29 lip 2025, 17:53 UTC

Major Market Movers

ZOOZ Shares Down; Plans $180 Million Private Placement for Bitcoin Reserve Strategy

29 lip 2025, 16:36 UTC

Major Market Movers

Antelope Enterprise Shares Drop After Securities Purchase Agreement

5 sie 2025, 13:55 UTC

Market Talk

Bitcoin Is Being Treated as a Portfolio Diversifier -- Market Talk

5 sie 2025, 08:43 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

5 sie 2025, 08:43 UTC

Market Talk

Bitcoin Eases Amid Tariff Uncertainty -- Market Talk

4 sie 2025, 08:37 UTC

Market Talk

Bitcoin Recovers as U.S. Rate-Cut Bets Rise -- Market Talk

1 sie 2025, 22:31 UTC

Earnings

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1 sie 2025, 08:22 UTC

Market Talk

Bitcoin Falls to Three-Week Low After Tariff News, Ahead of U.S. Data -- Market Talk

31 lip 2025, 21:26 UTC

Earnings

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 lip 2025, 20:43 UTC

Earnings

Riot Platforms 2Q Produced 1,426 Bitcoin, as Compared to 844 During the Same 3-Mo Period in 2024 >RIOT

31 lip 2025, 20:43 UTC

Earnings

Riot Platforms 2Q Rev $153M >RIOT

31 lip 2025, 20:31 UTC

Earnings

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 lip 2025, 15:30 UTC

Earnings

What MicroStrategy Earnings Tell Us About the Current State of Crypto Mania -- Barrons.com

31 lip 2025, 15:20 UTC

Earnings
Acquisitions, Mergers, Takeovers

Coinbase Reports Earnings This Afternoon. What to Watch. -- Barrons.com

31 lip 2025, 07:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

31 lip 2025, 07:36 UTC

Market Talk

Bitcoin Modestly Higher But Stays Below Key $120,000 Level -- Market Talk

30 lip 2025, 07:28 UTC

Market Talk

Bitcoin Edges Higher But Remains Stuck in a Range -- Market Talk

29 lip 2025, 21:45 UTC

Market Talk
Earnings

Visa Views Stablecoin as Growth Opportunity -- Market Talk

29 lip 2025, 21:21 UTC

Earnings

Visa CEO: U.S. Spend Growth Remained Strong in 2Q, No Noticeable Effects From Tariff

29 lip 2025, 21:19 UTC

Earnings

Visa CEO: Consumers Have Used Visa to Spend $25B in Cryptocurrencies Since 2020

29 lip 2025, 21:17 UTC

Earnings

Visa Is Best Way to Spend Money Using Stablecoins, CEO Says

29 lip 2025, 21:17 UTC

Earnings

Visa CEO: We Support Genius Act, Believe Stablecoins Can Solve Problems for Certain Use Cases

29 lip 2025, 17:38 UTC

Major Market Movers

ZOOZ Shares Down; Plans $180M Private Placement for Bitcoin Reserve Strategy

29 lip 2025, 14:05 UTC

Earnings

SoFi Stock Pops on Outlook Raise as Members Keep Piling In -- Update

29 lip 2025, 12:09 UTC

Market Talk

Stablecoin Regulation Could Support Dollar -- Market Talk

29 lip 2025, 09:43 UTC

Market Talk

Ethereum Could Rise Further on Corporate Treasury Purchases -- Market Talk

29 lip 2025, 08:24 UTC

Market Talk

Bitcoin Rises Slightly After U.S.-EU Trade Deal -- Market Talk

Peer Comparison

Price change

NeoGenomics Inc Forecast

Price Target

By TipRanks

63.84% upside

12 Months Forecast

Average 9.29 USD  63.84%

High 12 USD

Low 8 USD

Based on 11 Wall Street analysts offering 12 month price targets forNeoGenomics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

4

Buy

7

Hold

0

Sell

Technical Score

By Trading Central

7.7 / 10.27Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.